...
首页> 外文期刊>Modern rheumatology >A case of acquired hemophilia caused by factor VIII inhibitor with rheumatoid arthritis, successfully treated with immunosuppressive treatment and recombinant activated factor VII
【24h】

A case of acquired hemophilia caused by factor VIII inhibitor with rheumatoid arthritis, successfully treated with immunosuppressive treatment and recombinant activated factor VII

机译:风湿性关节炎的VIII因子抑制剂引起的获得性血友病一例,经免疫抑制治疗和重组激活的VII因子成功治疗

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

We report the case of a patient who presented with acquired hemophilia associated with rheumatoid arthritis. The patient's factor VIII activity was less than 1% and factor VIII inhibitor was detected. Based on the blood analysis, the patient was diagnosed as having the factor VIII inhibitor. She was successfully treated with prednisolone, cyclophosphamide, and gammaglobulin to suppress the factor VIII inhibitor, and the administration of recombinant activated factor VII was effective in controlling severe bleeding episodes.
机译:我们报告了一名患者,该患者出现与类风湿性关节炎相关的获得性血友病。患者的VIII因子活性低于1%,并且检测到VIII因子抑制剂。根据血液分析,诊断出该患者患有凝血因子VIII抑制剂。她已成功接受泼尼松龙,环磷酰胺和丙种球蛋白抑制因子VIII抑制剂的治疗,重组激活因子VII的给药可有效控制严重的出血发作。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号